166 related articles for article (PubMed ID: 34652284)
1. Lung cancer screening: a critical appraisal.
Kian W; Zemel M; Levitas D; Alguayn W; Remilah AA; Rahman NA; Peled N
Curr Opin Oncol; 2022 Jan; 34(1):36-43. PubMed ID: 34652284
[TBL] [Abstract][Full Text] [Related]
2. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
[TBL] [Abstract][Full Text] [Related]
3. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.
Lancaster HL; Heuvelmans MA; Oudkerk M
J Intern Med; 2022 Jul; 292(1):68-80. PubMed ID: 35253286
[TBL] [Abstract][Full Text] [Related]
4. Pearls and Pitfalls in Lung Cancer CT Screening.
Godoy MCB; Lago EAD; Pria HRFD; Shroff GS; Strange CD; Truong MT
Semin Ultrasound CT MR; 2022 Jun; 43(3):246-256. PubMed ID: 35688535
[TBL] [Abstract][Full Text] [Related]
5. Improving selection criteria for lung cancer screening. The potential role of emphysema.
Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
[TBL] [Abstract][Full Text] [Related]
6. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation.
Tanner NT; Gebregziabher M; Hughes Halbert C; Payne E; Egede LE; Silvestri GA
Am J Respir Crit Care Med; 2015 Jul; 192(2):200-8. PubMed ID: 25928649
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
[TBL] [Abstract][Full Text] [Related]
9. Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.
Gou HF; Liu Y; Yang TX; Zhou C; Chen XZ
Oncotarget; 2017 Jan; 8(1):1788-1795. PubMed ID: 27705946
[TBL] [Abstract][Full Text] [Related]
10. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.
Goulart BH; Ramsey SD
Oncologist; 2013; 18(8):941-6. PubMed ID: 23873718
[TBL] [Abstract][Full Text] [Related]
11. Performance of the cancer risk management model lung cancer screening module.
Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
[TBL] [Abstract][Full Text] [Related]
12. The evidence for low-dose CT screening of lung cancer.
Ruchalski K; Gutierrez A; Genshaft S; Abtin F; Suh R
Clin Imaging; 2016; 40(2):288-95. PubMed ID: 26362352
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
Silva M; Pastorino U; Sverzellati N
Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
[TBL] [Abstract][Full Text] [Related]
14. [Low-dose lung cancer screening programs - European outlook].
Kerpel-Fronius A
Magy Onkol; 2022 Oct; 66(3):202-206. PubMed ID: 36200500
[TBL] [Abstract][Full Text] [Related]
15. Update on Lung Cancer Screening.
Brownlee AR; Donington JS
Semin Respir Crit Care Med; 2020 Jun; 41(3):447-452. PubMed ID: 32450597
[TBL] [Abstract][Full Text] [Related]
16. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
17. Impact of Low-Dose Computed Tomography Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis.
Su CC; Wu JT; Neal JW; Popat RA; Kurian AW; Backhus LM; Nagpal S; Leung AN; Wakelee HA; Han SS
J Thorac Oncol; 2021 Sep; 16(9):1479-1489. PubMed ID: 34091050
[TBL] [Abstract][Full Text] [Related]
18. Lung Cancer Screening: Computed Tomography Radiation and Protocols.
Murugan VA; Kalra MK; Rehani M; Digumarthy SR
J Thorac Imaging; 2015 Sep; 30(5):283-9. PubMed ID: 25856411
[TBL] [Abstract][Full Text] [Related]
19. EUPS-argues that lung cancer screening should be implemented in 18 months.
Field JK; Baldwin DR; Devaraj A; Oudkerk M
Br J Radiol; 2018 Oct; 91(1090):20180243. PubMed ID: 29722546
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
